Zai Lab On Portfolio Strategy In Post Coronavirus China

Adapting To Changing Oncology Market

 
• By Brian Yang
  
Shanghai overpass
SHANGHAI'S ZAI LAB EXPANDS PORTFOLIO TO COMPETE IN POST-CORONAVIRUS CHINA • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia